- Home
- GSK vs MRSH Comparison
GSK vs MRSH Comparison
Compare GSK & MRSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GSK | MRSH |
|---|---|---|
| Founded | 1715 | 1871 |
| Country | United Kingdom | United States |
| Employees | 66841 | 55700 |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7B | 90.5B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | GSK | MRSH |
|---|---|---|
| Price | $52.95 | $191.61 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 2 | 11 |
| Target Price | N/A | ★ $199.27 |
| AVG Volume (30 Days) | ★ 4.3M | 2.4M |
| Earning Date | 04-29-2026 | 04-16-2026 |
| Dividend Yield | ★ 3.40% | 2.11% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $6.99 | $6.85 |
| Revenue Next Year | $4.19 | $4.70 |
| P/E Ratio | $32.75 | ★ $21.13 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $37.71 | $156.60 |
| 52 Week High | $61.70 | $198.49 |
Technical Indicators
Market Signals| Indicator | GSK | MRSH |
|---|---|---|
| Relative Strength Index (RSI) | 51.84 | 63.93 |
| Support Level | $49.92 | $175.14 |
| Resistance Level | $53.87 | $195.91 |
| Average True Range (ATR) | 1.06 | 4.60 |
| MACD | -0.00 | 0.39 |
| Stochastic Oscillator | 38.68 | 78.24 |
Price Performance
Historical ComparisonAbout GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About MRSH Marsh Common Stock
Marsh is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.